# SYMTUZA
> **NDA210455** · New Drug Application · Sponsor: JANSSEN PRODS · Approved 2018-07-17
## Drug
- **FDA Application Number:** NDA210455
- **Application type:** New Drug Application
- **Brand name:** SYMTUZA
- **Generic name:** DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE
- **Active ingredients:** COBICISTAT; DARUNAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** JANSSEN PRODS
- **Manufacturer:** Janssen Products LP
- **First approval:** 2018-07-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210455)
---
*MORVS · CC0 1.0*